Thinking Allowed

medical / technology / education / art / flub

showing posts for 'increasingly'

Traces #4 by Mike Caulfield: The Coming Annotation Wars: I went to the iAnnotate conference last week and it was lovely.

Traces #4 by Mike Caulfield: The Coming Annotation Wars: I went to the iAnnotate conference last week and it was lovely. Annotation is slowly coming into its own as a technology; I tend to think of it as a way to "re-webify" a web that has increasingly move...
Source: tinyletter.com

A Serious Game for Learning C Programming Language Concepts Using Solo Taxonomy: This paper conducts a study to identify

A Serious Game for Learning C Programming Language Concepts Using Solo Taxonomy: This paper conducts a study to identify pedagogical approaches and gameplay techniques involved in the development of serious games for teaching scientific courses in general especially programming languages. The concept...
Source: online-journals.org

Insulin Pricing Target of Class Action Lawsuit: By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco,

Insulin Pricing Target of Class Action Lawsuit: By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Three companies that supply insulin in the U.S. are accused of conspiring to set increasingly higher prices for … NEJM Journal Watch.
Source: jwatch.org

E-learning predictions for 2017. Joining the folly of futurists and pollsters here are my e-learning predictions for 2017.

blog post image E-learning predictions for 2017. Joining the folly of futurists and pollsters here are my e-learning predictions for 2017. I'm looking forward to engaging with as many of them as I can. Conversational technology. Why not have immediate access and personal learning support on platforms through messaging...
Source: agnate.co.uk

U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of

U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort.
Source: reuters.com